{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T20:29:10Z","timestamp":1773952150751,"version":"3.50.1"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"13","funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe Saarland Staatskanzlei","doi-asserted-by":"publisher","award":["109752"],"award-info":[{"award-number":["109752"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Neoadjuvant radio\/chemotherapy regimens can markedly improve cervical cancer outcome in a subset of patients, while other patients show poor responses, but may encounter severe adverse effects. Thus, there is a strong need for predictive biomarkers to improve clinical management of cervical cancer patients. STAT3 is considered as a critical antiapoptotic factor in various malignancies. We therefore investigated STAT3 activation during cervical carcinogenesis and its impact on the response of cervical cancer cells to chemotherapeutic drugs. Tyr705-phosphorylated STAT3 increased from low-grade cervical intraepithelial neoplasia (CIN1) to precancerous CIN3 lesions. Notably, pTyr705-STAT3 activation significantly declined from CIN3 to invasive cancer, also when compared in the same clinical biopsy. pTyr705-STAT3 was also low or absent in cultured human cervical cancer cell lines, consistent with the in vivo expression data. Unexpectedly, IL6-type cytokine signaling inducing STAT3 activation rendered cervical cancer cells significantly more susceptible to chemotherapeutic drugs, that is, cisplatin or etoposide. This chemosensitization was STAT3-dependent and we identified IFN regulatory factor-1 (IRF1) as the STAT3-inducible mediator required for cell death enhancement. In line with these data, pTyr705-STAT3 significantly correlated with nuclear IRF1 expression in cervical cancer in vivo. Importantly, high IRF1 expression in pretreatment cervical cancer biopsy cells was associated with a significantly better response to neoadjuvant radio\/chemotherapy of the patients. In summary, our study has identified a key role of the STAT3\/IRF1 pathway for chemosensitization in cervical cancer. Our results suggest that pretherapeutic IRF1 expression should be evaluated as a novel predictive biomarker for neoadjuvant radio\/chemotherapy responses. Cancer Res; 76(13); 3872\u201383. \u00a92016 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-14-1306","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T12:29:40Z","timestamp":1464092980000},"page":"3872-3883","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["STAT3\/IRF1 Pathway Activation Sensitizes Cervical Cancer Cells to Chemotherapeutic Drugs"],"prefix":"10.1158","volume":"76","author":[{"given":"Barbara","family":"Walch-R\u00fcckheim","sequence":"first","affiliation":[{"name":"1Institute of Virology, Saarland University, Homburg\/Saar, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Pahne-Zeppenfeld","sequence":"additional","affiliation":[{"name":"2Center for Molecular Medicine Cologne and Institute of Virology, University of Cologne, Cologne, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jil","family":"Fischbach","sequence":"additional","affiliation":[{"name":"1Institute of Virology, Saarland University, Homburg\/Saar, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Wickenhauser","sequence":"additional","affiliation":[{"name":"3Institute of Pathology, University of Halle, Halle, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars Christian","family":"Horn","sequence":"additional","affiliation":[{"name":"4Institute of Pathology, University of Leipzig, Leipzig, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Tharun","sequence":"additional","affiliation":[{"name":"5Institute of Pathology, University of Cologne, Cologne, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"B\u00fcttner","sequence":"additional","affiliation":[{"name":"5Institute of Pathology, University of Cologne, Cologne, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Mallmann","sequence":"additional","affiliation":[{"name":"6Department of Gynecology and Obstetrics, University of Cologne, Cologne, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Stern","sequence":"additional","affiliation":[{"name":"7Institute of Cancer Sciences, University of Manchester, Manchester, United Kingdom."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoo-Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"8Institute of Pathology, Saarland University, Homburg\/Saar, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer Maria","family":"Bohle","sequence":"additional","affiliation":[{"name":"8Institute of Pathology, Saarland University, Homburg\/Saar, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"R\u00fcbe","sequence":"additional","affiliation":[{"name":"9Department of Radiotherapy and Radiation Oncology, Saarland University, Homburg\/Saar, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russalina","family":"Str\u00f6der","sequence":"additional","affiliation":[{"name":"10Department of Gynecology and Obstetrics, Saarland University, Homburg\/Saar, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingolf","family":"Juhasz-B\u00f6ss","sequence":"additional","affiliation":[{"name":"10Department of Gynecology and Obstetrics, Saarland University, Homburg\/Saar, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erich-Franz","family":"Solomayer","sequence":"additional","affiliation":[{"name":"10Department of Gynecology and Obstetrics, Saarland University, Homburg\/Saar, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrun","family":"Smola","sequence":"additional","affiliation":[{"name":"1Institute of Virology, Saarland University, Homburg\/Saar, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2016,6,30]]},"reference":[{"key":"2022061705112931100_bib1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2008.11.046","article-title":"Papillomaviruses in the causation of human cancers - a brief historical account","volume":"384","author":"zur Hausen","year":"2009","journal-title":"Virology"},{"key":"2022061705112931100_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000381461","article-title":"Dose-dense neoadjuvant chemotherapy plus radical surgery in locally advanced cervical cancer: a phase II study","volume":"89","author":"Benedetti Panici","year":"2015","journal-title":"Oncology"},{"key":"2022061705112931100_bib3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/jmri.24784","article-title":"Monitoring treatment response in patients undergoing chemoradiotherapy for locally advanced uterine cervical cancer by additional diffusion-weighted imaging: a systematic review","volume":"42","author":"Schreuder","year":"2015","journal-title":"J Magn Reson Imaging"},{"key":"2022061705112931100_bib4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0305-7372(03)00117-8","article-title":"Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer","volume":"29","author":"Maduro","year":"2003","journal-title":"Cancer Treat Rev"},{"key":"2022061705112931100_bib5","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2174\/1389450115666141120104146","article-title":"The role of STAT3 signaling in mediating tumor resistance to cancer therapy","volume":"15","author":"Tan","year":"2014","journal-title":"Curr Drug Targets"},{"key":"2022061705112931100_bib6","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1200\/JCO.2010.31.8907","article-title":"Targeting the interleukin-6\/Jak\/stat pathway in human malignancies","volume":"30","author":"Sansone","year":"2012","journal-title":"J Clin Oncol"},{"key":"2022061705112931100_bib7","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1158\/0008-5472.CAN-12-2353","article-title":"Critical role of STAT3 in IL-6-mediated drug resistance in human neuroblastoma","volume":"73","author":"Ara","year":"2013","journal-title":"Cancer Res"},{"key":"2022061705112931100_bib8","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1158\/0008-5472.CAN-15-1122","article-title":"STAT3 Inhibition enhances the therapeutic efficacy of immunogenic chemotherapy by stimulating type 1 interferon production by cancer cells","volume":"75","author":"Yang","year":"2015","journal-title":"Cancer Res"},{"key":"2022061705112931100_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nri1995","article-title":"Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment","volume":"7","author":"Yu","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"2022061705112931100_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1158\/0008-5472.CAN-10-2193","article-title":"Molecular pathobiology of human cervical high-grade lesions: paracrine STAT3 activation in tumor-instructed myeloid cells drives local MMP-9 expression","volume":"71","author":"Schroer","year":"2011","journal-title":"Cancer Res"},{"key":"2022061705112931100_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.immunol.23.021704.115806","article-title":"INTERLEUKIN-6: from basic science to medicine-40 years in immunology","volume":"23","author":"Kishimoto","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"2022061705112931100_bib12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.smim.2014.01.001","article-title":"IL-6 and related cytokines as the critical lynchpins between inflammation and cancer","volume":"26","author":"Taniguchi","year":"2014","journal-title":"Semin Immunol"},{"key":"2022061705112931100_bib13","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1002\/j.1460-2075.1996.tb00734.x","article-title":"A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells","volume":"15","author":"Nakajima","year":"1996","journal-title":"EMBO J"},{"key":"2022061705112931100_bib14","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1182\/blood.V92.10.3495.422k47_3495_3504","article-title":"Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis","volume":"92","author":"Peters","year":"1998","journal-title":"Blood"},{"key":"2022061705112931100_bib15","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.4049\/jimmunol.165.4.1939","article-title":"Loss of IL-6 receptor expression in cervical carcinoma cells inhibits autocrine IL-6 stimulation: abrogation of constitutive monocyte chemoattractant protein-1 production","volume":"165","author":"Hess","year":"2000","journal-title":"J Immunol"},{"key":"2022061705112931100_bib16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1525-1438.2003.13197.x","article-title":"A prognostic insight on in vivo expression of interleukin-6 in uterine cervical cancer","volume":"13","author":"Srivani","year":"2003","journal-title":"Int J Gynecol Cancer"},{"key":"2022061705112931100_bib17","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/ijc.28549","article-title":"Cervical cancer cell-derived interleukin-6 impairs CCR7-dependent migration of MMP-9-expressing dendritic cells","volume":"134","author":"Pahne-Zeppenfeld","year":"2014","journal-title":"Int J Cancer"},{"key":"2022061705112931100_bib18","doi-asserted-by":"crossref","first-page":"5248","DOI":"10.1158\/0008-5472.CAN-15-0732","article-title":"Stromal fibroblasts induce CCL20 through IL6\/C\/EBPbeta to support the recruitment of Th17 Cells during cervical cancer progression","volume":"75","author":"Walch-Ruckheim","year":"2015","journal-title":"Cancer Res"},{"key":"2022061705112931100_bib19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1006\/viro.1999.9722","article-title":"Response to IL-6 of HPV-18 cervical carcinoma cell lines","volume":"258","author":"Bauknecht","year":"1999","journal-title":"Virology"},{"key":"2022061705112931100_bib20","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.18632\/oncotarget.3249","article-title":"RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1alpha release, and efficient paracrine dendritic cell activation","volume":"6","author":"Schmidt","year":"2015","journal-title":"Oncotarget"},{"key":"2022061705112931100_bib21","first-page":"138","article-title":"[Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]","volume":"8","author":"Remmele","year":"1987","journal-title":"Pathologe"},{"key":"2022061705112931100_bib22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1034\/j.1399-0039.2000.550502.x","article-title":"Multiple mechanisms underlie HLA dysregulation in cervical cancer","volume":"55","author":"Brady","year":"2000","journal-title":"Tissue Antigens"},{"key":"2022061705112931100_bib23","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/jnci\/djh031","article-title":"TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia","volume":"96","author":"Steenbergen","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"2022061705112931100_bib24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1083\/jcb.122.2.417","article-title":"Mutual induction of growth factor gene expression by epidermal-dermal cell interaction","volume":"122","author":"Smola","year":"1993","journal-title":"J Cell Biol"},{"key":"2022061705112931100_bib25","doi-asserted-by":"crossref","first-page":"e1002833","DOI":"10.1371\/journal.ppat.1002833","article-title":"Human papillomavirus type 8 interferes with a novel C\/EBPbeta-mediated mechanism of keratinocyte CCL20 chemokine expression and Langerhans cell migration","volume":"8","author":"Sperling","year":"2012","journal-title":"PLoS Pathog"},{"key":"2022061705112931100_bib26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/377362a0","article-title":"Activation of a cell-cycle-regulated histone gene by the oncogenic transcription factor IRF-2","volume":"377","author":"Vaughan","year":"1995","journal-title":"Nature"},{"key":"2022061705112931100_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1084\/jem.183.1.159","article-title":"A novel function of CD40: induction of cell death in transformed cells","volume":"183","author":"Hess","year":"1996","journal-title":"J Exp Med"},{"key":"2022061705112931100_bib28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1128\/JVI.00998-10","article-title":"Differential regulation of human papillomavirus type 8 by interferon regulatory factors 3 and 7","volume":"85","author":"Oldak","year":"2011","journal-title":"J Virol"},{"key":"2022061705112931100_bib29","first-page":"4633","article-title":"Endogenous interleukin 6 is a resistance factor for cis-diamminedichloroplatinum and etoposide-mediated cytotoxicity of human prostate carcinoma cell lines","volume":"55","author":"Borsellino","year":"1995","journal-title":"Cancer Res"},{"key":"2022061705112931100_bib30","first-page":"3063","article-title":"Evaluation of oral etoposide in combination with cisplatin for patients with recurrent cervical cancer: long-term follow-up results of a Japanese multicenter study","volume":"31","author":"Watanabe","year":"2011","journal-title":"Anticancer Res"},{"key":"2022061705112931100_bib31","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/sj.onc.1207023","article-title":"IRF-1 expression induces apoptosis and inhibits tumor growth in mouse mammary cancer cells invitro and invivo","volume":"23","author":"Kim","year":"2004","journal-title":"Oncogene"},{"key":"2022061705112931100_bib32","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1172\/JCI200421032","article-title":"Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis","volume":"114","author":"Chan","year":"2004","journal-title":"J Clin Invest"},{"key":"2022061705112931100_bib33","doi-asserted-by":"crossref","first-page":"7938","DOI":"10.1158\/0008-5472.CAN-10-1128","article-title":"Keratinocyte-specific stat3 heterozygosity impairs development of skin tumors in human papillomavirus 8 transgenic mice","volume":"70","author":"De Andrea","year":"2010","journal-title":"Cancer Res"},{"key":"2022061705112931100_bib34","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/sj.bjc.6605212","article-title":"Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinoma","volume":"101","author":"Takemoto","year":"2009","journal-title":"Br J Cancer"},{"key":"2022061705112931100_bib35","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/sj.bjc.6603597","article-title":"Stat3 activation in human endometrial and cervical cancers","volume":"96","author":"Chen","year":"2007","journal-title":"Br J Cancer"},{"key":"2022061705112931100_bib36","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.ijrobp.2010.11.043","article-title":"Constitutive STAT5 activation correlates with better survival in cervical cancer patients treated with radiation therapy","volume":"82","author":"Chen","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2022061705112931100_bib37","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1607-551X(09)70350-X","article-title":"Positive association between STAT3 and Ki-67 in cervical intraepithelial neoplasia","volume":"22","author":"Yang","year":"2006","journal-title":"Kaohsiung J Med Sci"},{"key":"2022061705112931100_bib38","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/1476-4598-9-282","article-title":"Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection","volume":"9","author":"Shukla","year":"2010","journal-title":"Mol Cancer"},{"key":"2022061705112931100_bib39","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.immunol.26.021607.090400","article-title":"The IRF family transcription factors in immunity and oncogenesis","volume":"26","author":"Tamura","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"2022061705112931100_bib40","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/carcin\/bgi113","article-title":"Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis","volume":"26","author":"Bouker","year":"2005","journal-title":"Carcinogenesis"},{"key":"2022061705112931100_bib41","first-page":"S6","article-title":"Genome-wide identification of IRF1 binding sites reveals extensive occupancy at cell death associated genes","author":"Rettino","year":"2013","journal-title":"J Carcinog Mutagen"},{"key":"2022061705112931100_bib42","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1158\/0008-5472.CAN-14-1851","article-title":"Interferon regulatory factor-1 signaling regulates the switch between autophagy and apoptosis to determine breast cancer cell fate","volume":"75","author":"Schwartz-Roberts","year":"2015","journal-title":"Cancer Res"},{"key":"2022061705112931100_bib43","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/carcin\/bgp150","article-title":"Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1","volume":"30","author":"Lace","year":"2009","journal-title":"Carcinogenesis"},{"key":"2022061705112931100_bib44","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.virol.2009.12.025","article-title":"Interferon regulatory factor (IRF)-2 activates the HPV-16 E6-E7 promoter in keratinocytes","volume":"399","author":"Lace","year":"2010","journal-title":"Virology"},{"key":"2022061705112931100_bib45","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1128\/JVI.02114-10","article-title":"Human papillomavirus type 16 E5 protein induces expression of beta interferon through interferon regulatory factor 1 in human keratinocytes","volume":"85","author":"Muto","year":"2011","journal-title":"J Virol"},{"key":"2022061705112931100_bib46","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1099\/vir.0.054486-0","article-title":"Human papillomavirus 16-encoded E7 protein inhibits IFN-gamma-mediated MHC class I antigen presentation and CTL-induced lysis by blocking IRF-1 expression in mouse keratinocytes","volume":"94","author":"Zhou","year":"2013","journal-title":"J Gen Virol"},{"key":"2022061705112931100_bib47","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3835(01)00871-0","article-title":"Abrogation of IRF-1 response by high-risk HPV E7 protein invivo","volume":"179","author":"Um","year":"2002","journal-title":"Cancer Lett"},{"key":"2022061705112931100_bib48","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1073\/pnas.93.9.3963","article-title":"STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line","volume":"93","author":"Minami","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061705112931100_bib49","first-page":"269","article-title":"Functional analysis of the effect of forced activation of STAT3 on M1 mouse leukemia cells","volume":"15","author":"Yoshida","year":"2005","journal-title":"Int J Mol Med"},{"key":"2022061705112931100_bib50","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10549-009-0509-8","article-title":"Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancer","volume":"121","author":"Cavalli","year":"2010","journal-title":"Breast Cancer Res Treat"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/76\/13\/3872\/2736149\/3872.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/76\/13\/3872\/2736149\/3872.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T11:58:51Z","timestamp":1655467131000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/76\/13\/3872\/613632\/STAT3-IRF1-Pathway-Activation-Sensitizes-Cervical"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,30]]},"references-count":50,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2016,6,30]]},"published-print":{"date-parts":[[2016,7,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-14-1306","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22409885.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409903.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409891.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409870.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409894.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409903","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409906","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409906.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409888","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409876.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409879.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409879","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409885","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409897.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409897","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409876","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409891","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409870","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409894","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409888.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6507872.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6507872","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,30]]}}}